Cytek BioSciences Inc’s recently made public that its CHIEF TECHNOLOGY OFFICER Yan Ming unloaded Company’s shares for reported $0.12 million on Apr 19 ’24. In the deal valued at $5.87 per share,20,000 shares were sold. As a result of this transaction, Yan Ming now holds 5,988,502 shares worth roughly $37.19 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Yan Ming sold 1,900 shares, generating $13,304 in total proceeds. Upon selling the shares at $7.00, the CHIEF TECHNOLOGY OFFICER now owns 6,008,502 shares.
Before that, Yan Ming sold 20,000 shares. Cytek BioSciences Inc shares valued at $135,400 were divested by the CHIEF TECHNOLOGY OFFICER at a price of $6.77 per share. As a result of the transaction, Yan Ming now holds 6,030,402 shares, worth roughly $37.45 million.
Stephens initiated its Cytek BioSciences Inc [CTKB] rating to an Overweight in a research note published on December 14, 2023; the price target was $9. A number of analysts have revised their coverage, including Raymond James’s analysts, who began to cover the stock in mid July with a ‘”a Mkt perform”‘ rating.
Price Performance Review of CTKB
On Friday, Cytek BioSciences Inc [NASDAQ:CTKB] saw its stock fall -4.02% to $6.21. Over the last five days, the stock has lost -4.02%. Cytek BioSciences Inc shares have fallen nearly -31.91% since the year began. Nevertheless, the stocks have fallen -22.57% over the past one year. While a 52-week high of $9.87 was reached on 03/04/24, a 52-week low of $4.66 was recorded on 10/25/24. SMA at 50 days reached $5.90, while 200 days put it at $5.96.
Levels Of Support And Resistance For CTKB Stock
The 24-hour chart illustrates a support level at 6.07, which if violated will result in even more drops to 5.93. On the upside, there is a resistance level at 6.39. A further resistance level may holdings at 6.57. The Relative Strength Index (RSI) on the 14-day chart is 46.71, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.17, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 87.73%. Stochastics %K at 33.43% indicates the stock is a holding.
How much short interest is there in Cytek BioSciences Inc?
A steep rise in short interest was recorded in Cytek BioSciences Inc stocks on 2024-11-29, dropping by -0.25 million shares to a total of 3.95 million shares. Yahoo Finance data shows the prior-month short interest on 2024-10-31 was 4.2 million shares. There was a decline of -6.31%, which implies that there is a negative sentiment for the stock.
